LataMed AI Corp.
OOTC:LMED0.05
USD
+0.00
(+3.26%)
CIK
1477960
ISIN
US21116R4048
CUSIP
21116R404
Return %
Stock
S&P 500
1Y
-64.18
14.20
3Y
-99.73
81.12
5Y
-99.90
68.34
Capital Structure
USD
•
in mil. unless spec.Working Capital
USD
•
in mil. unless spec.Growth Rates
USD
•
in mil. unless spec.Quarterly Revenue
USD
•
in mil. unless spec.Quarterly Earnings Per Share
USD
•
in mil. unless spec.Quarterly Dividends Per Share
USD
•
in mil. unless spec.Company Description
- CEO
- Kevin Rodan Levy
- Full Time Employees
- - -
- Sector
- Finance
- Industry
- Financial conglomerates
- Address
- Sheridan United States
- IPO Date
- Oct 13, 2010
- CIK
- 0001477960
- Website
- catalystcrew.ai
- Similar Companies
- Business
- LataMed AI Corp. is a healthcare technology company that specializes in artificial intelligence-powered digital health infrastructure, telemedicine platforms, and clinical data analytics for emerging markets, with a primary operational focus on Latin America. The company designs, develops, and deploys a comprehensive portfolio of digital health solutions, including a consumer and provider mobile healthcare application featuring integrated telemedicine consultations, electronic medical records management, automated scheduling, and a personal AI healthcare assistant; artificial intelligence-driven diagnostic and clinical analytics platforms that facilitate patient risk stratification, clinical decision support, and intelligent triage; an industrial telemedicine and occupational health platform tailored for remote and high-risk operational environments, such as offshore oil and gas facilities, offering remote vitals monitoring, emergency clinical coordination, and hybrid on-site care delivery; an emergency medical response system utilizing geolocation technology for rapid emergency dispatch, triage prioritization, and real-time medical logistics; and specialized enterprise workflow software for pharmaceutical distributors and diagnostic laboratories providing automated quality control, inventory analytics, and laboratory documentation management. Incorporated in Nevada in 2008, the company is headquartered in Sheridan, Wyoming, and operates regionally through its Venezuelan subsidiary, LataMed AI VE, based in Caracas, Venezuela. LataMed AI Corp. recently completed a comprehensive strategic reorganization, pivoting its core business model from general technology and business consulting to healthcare artificial intelligence, which included a formal corporate name change from Catalyst Crew Technologies Corp. to LataMed AI Corp. in 2026. In July 2026, the company executed a 5-for-1 forward stock split of its common stock, trading under the temporary symbol LMEDD before reverting to LMED on the OTC market. Operationally, the company has expanded its regional footprint through multiple strategic agreements, including a public-sector collaboration with the Venezuelan Ministry of Popular Power for Science and Technology (Mincyt) and the Ministry of Popular Power for Health (MPPS) to implement AI-assisted triage and digital healthcare systems across public health facilities in the State of La Guaira; a commercial agreement with pharmaceutical distributor DROGUERIAS LALA C.A. to implement automated laboratory and distribution workflow software; infrastructure integration agreements with telecommunications providers to broaden telehealth connectivity; health monitoring partnerships with academic and athletic organizations including Caracas FC; and the advancement of its proprietary mobile application to the final deployment stage on major digital distribution platforms.